Neurogene Inc
NASDAQ:NGNE

Watchlist Manager
Neurogene Inc Logo
Neurogene Inc
NASDAQ:NGNE
Watchlist
Price: 20.28 USD -4.16% Market Closed
Market Cap: 314.1m USD

Wall Street
Price Targets

NGNE Price Targets Summary
Neurogene Inc

Wall Street analysts forecast NGNE stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for NGNE is 60.18 USD with a low forecast of 46.46 USD and a high forecast of 73.5 USD.

Lowest
Price Target
46.46 USD
129% Upside
Average
Price Target
60.18 USD
197% Upside
Highest
Price Target
73.5 USD
262% Upside
Neurogene Inc Competitors:
Price Targets
2696
Shanghai Henlius Biotech Inc
50% Upside
2171
CARsgen Therapeutics Holdings Ltd
27% Upside
RPTX
Repare Therapeutics Inc
38% Upside
SKYE
Skye Bioscience Inc
641% Upside
AUPH
Aurinia Pharmaceuticals Inc
9% Upside
7774
Japan Tissue Engineering Co Ltd
144% Upside
ACLX
Arcellx Inc
64% Upside
PLUR
Pluri Inc
273% Upside

Revenue
Forecast

Revenue Estimate
Neurogene Inc

N/A
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average

Operating Income
Forecast

Operating Income Estimate
Neurogene Inc

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-4%
Average Miss

Net Income
Forecast

Net Income Estimate
Neurogene Inc

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-92%
Average Miss
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is NGNE's stock price target?
Price Target
60.18 USD

According to Wall Street analysts, the average 1-year price target for NGNE is 60.18 USD with a low forecast of 46.46 USD and a high forecast of 73.5 USD.

Back to Top